The federal government has been—and must remain—a critical partner in foundational technological innovation and research ...
In a city, coworking hubs bring people and ideas together. Inside cancer cells, similar hubs form—but instead of fueling ...
Anthropic is doubling down on medical science with Claude for Life Sciences, a specialized AI designed to integrate deeply ...
The Series C round was led by Alphabet Inc.’s GV fund. Sequoia, Kleiner Perkins, Blackstone, Thrive Capital, Coatue, Bond and ...
Tolremo therapeutics completes first in human dose escalation for TT125-802 and presents solid tumour monotherapy results at ESMO 2025: Basel Monday, October 20, 2025, 15:30 Hrs [ ...
First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapiesTopline safety, ...
David Crisafulli may not have won over all of southeast Queensland just yet but most of the state seems to be behind the ...
Illustration of voltage-matrix nanopore profiling. The artistic rendering depicts proteins (colored shapes) being analyzed by solid-state nanopores ...
Stoke Therapeutics, Inc. , a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicines, today announced the presentation of two-year data ...
Zacks Investment Research on MSN
PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, announced innovations to its Revio and Vega platforms last week. The innovations are expected to lower sequencing costs, add ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results